Latest News about NVO
Recent news which mentions NVO
The 3 Hottest Healthcare ETFs to Buy in 2024
February 26, 2024
From InvestorPlace
Future Juggernauts: The Next 7 Trillion Dollar Companies to Buy Now
February 26, 2024
From InvestorPlace
Amgen's Upcoming Catalysts In 2024 Set To Unlock Multi-Billion Dollar Markets, Says Goldman Sachs
February 26, 2024
From Benzinga
From Benzinga
Tickers
NVO
From Motley Fool
Obesity Solutions Like Weight Loss Drugs To Act As Catalyst For Economic Surge, Goldman Sachs Forecasts
February 23, 2024
From Benzinga
Global Access to Weight-Loss Treatments: Indian Pharma Giants Eye Affordable Wegovy Alternatives Amid Rising Demand
February 22, 2024
From Benzinga
Move Over Magnificent 7, Say Hello to the GRANOLAS
February 22, 2024
From InvestorPlace
2 No-Brainer Biotech Stocks to Buy Right Now
February 21, 2024
From Motley Fool
Weight-Loss Drugs Vs. Conagra Foods: Company Optimistic Amid Shifting Consumer Demands Influenced By Hunger Suppressing
February 21, 2024
From Benzinga
3 Top Sectors Investment Dollars Are Pouring Into Now: February 2024
February 20, 2024
From InvestorPlace
3 Cheap Dividend Stocks to Snatch Up Now
February 20, 2024
From InvestorPlace
Ozempic Effect: Food Industry Feels The Heat As Weight-Loss Drugs Get Popular, Investors Call For Menu Makeovers
February 20, 2024
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
February 19, 2024
From Benzinga
Novo Nordisk Has More Than Ozempic. One of Its Other Treatments Grew 393% Last Year.
February 18, 2024
Tickers
NVO
From Motley Fool
Wealth Generators: 3 Growth Stocks You’ll Regret Not Buying in 2024
February 18, 2024
From InvestorPlace
Meet the Next Trillion-Dollar Companies: Our Top 7 Picks
February 15, 2024
From InvestorPlace
UK Becomes First Major Market for Eli Lilly's Mounjaro Prefilled Pen For Tackling Obesity
February 15, 2024
From Benzinga
What's Gaining Popularity Among US Teens Battling Obesity? Novo Nordisk's Weight Loss Drug Wegovy
February 15, 2024
From Benzinga
7 Must-Buy Pharma Stocks Amid the Weight Loss Drug Revolution
February 14, 2024
From InvestorPlace
Tickers
NVO
From Motley Fool
Amgen Takes Aim at Novo Nordisk and Eli Lilly, but Is the Stock a Buy?
February 14, 2024
From Motley Fool
Kerrisdale Capital Slams Altimmune (ALT) Stock in New Short Report
February 13, 2024
From InvestorPlace
Altimmune Stock Sinks As Kerrisdale Capital Announces Short Position: 'Obvious Dead End'
February 13, 2024
From Benzinga
Here's How Much You Would Have Made Owning Novo Nordisk Stock In The Last 10 Years
February 13, 2024
From Benzinga
Move Aside, Eli Lilly and Novo Nordisk. Wall Street Thinks This Stock Will Be a Bigger Winner Over the Next 12 Months.
February 13, 2024
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
February 12, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free
Information
Copyright 2024. BUSINESS INSURANCE HOLDINGS
